Recurrent paradoxical reactions as non-communicating hydrocephalus and basal meningitis in a non-HIV patient with tuberculous meningitis and tuberculoma
Abstract
BACKGROUND: Tuberculosis meningitisis the most devastating form of Tuberculosis, causing high mortality or disability. Paradoxical neuro-inflammatory reactions, which occur despite appropriate anti-TB chemotherapy, may reflect the host response to dead and dying bacterial.
CASE REPORT: We report a case involving paradoxical reaction, effectively managed with emergent external ventricular drainage (EVD). The patient, a healthy 30-year-old Burmese woman, was diagnosed with disseminated tuberculosis involving pulmonary disease, vertebral osteomyelitis, and meningitis. Treatment included isoniazid (INH) 300 mg/day, rifampicin (RFP) 450 mg/day, ethambutol (EB) 750 mg/day, pyrazinamide (PZA) 1250 mg/day, levofloxacin (LVFX) 500 mg/day, and Dexamethasone (DEX) 0.4 mg/kg/day. A week after treatment initiation, she experienced the a paradoxical reaction but found relief with symptomatic treatment. Due to susceptibility of tuberculosis, we transitioned her to INH+RFP+LVFX, and DEXA was discontinued after two months. On day 66, she was readmitted with worsening symptoms and was diagnosed with a second paradoxical reaction and hydrocephalus. Neurosurgery inserted an EVD tube and resumed DEXA. The patient showed significant improvement, and the EVD was subsequently removed. DEXA was stopped after 4 months.There was no recurrence in one year.
CONCLUSION: During the treatment of TBM, a paradoxical reaction can occur at any time. Therefore, we recommend the necessity of collaborating with a…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.